Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$460,712,867
-$20,126,276 QoQ
Shares Held
7,995,711
+0.9% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#38
of 2,506 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $1,720,661,138 across 10 Drug Manufacturers - General names. BMY ranks #1 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
This page
|
7,995,711 | $460,712,867 | |
| 2 | PFE |
Pfizer Inc
|
16,793,903 | $404,397,184 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,110,000 | $392,917,400 | |
| 4 | BIIB |
Biogen Inc.
|
1,122,981 | $242,631,274 | |
| 5 | LLY |
ELI LILLY & Co
|
59,898 | $71,843,464 | |
| 6 | ABBV |
AbbVie Inc.
|
201,334 | $50,663,687 | |
| 7 | JNJ |
Johnson & Johnson
|
183,172 | $46,520,192 | |
| 8 | AMGN |
Amgen Inc
|
74,159 | $26,854,457 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $460,712,867 | 7,995,711 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $480,839,143 | 7,928,098 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $451,970,757 | 8,379,139 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $419,641,879 | 9,304,698 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $449,727,810 | 9,715,442 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $545,433,082 | 8,942,992 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $559,579,583 | 9,893,557 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $564,877,969 | 10,917,626 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $507,131,219 | 12,211,202 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $496,039,369 | 9,146,955 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $401,805,941 | 7,830,948 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $307,065,727 | 5,290,588 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $258,405,450 | 4,040,742 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $280,641,180 | 4,049,072 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $13,381,045 | 185,977 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $155,048,427 | 2,181,016 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $148,566,495 | 1,929,435 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $92,229,002 | 1,262,892 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $38,603,503 | 619,142 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $27,046,962 | 457,106 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $26,017,369 | 389,365 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $16,800,092 | 266,119 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $16,104,414 | 259,623 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $14,514,757 | 240,749 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $11,653,513 | 198,189 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||